Bacterial blocking activity of specific IgG in chronic Pseudomonas aeruginosa infection
- PMID: 54231
- PMCID: PMC1538033
Bacterial blocking activity of specific IgG in chronic Pseudomonas aeruginosa infection
Abstract
A factor has been demonstrated in the serum of some patients with chronic Gram-negative infections which specifically blocks bactericidal activity against the infecting organism. Sera with this factor, that had been obtained from patients suffering from chronic Pseudomonas aeruginosa infections, were fractionated by Sephadex G-200 and DEAE-Sephadex column chromatography. Blocking activity was detected in the Sephadex G-200 '7S' peak and eluted from the DEAE column along with the serum IgG. Immunoelectrophoresis studies of this material along with pure IgG showed that the bactericidal blocking factor in these patients was IgG. The blocking factor was specific in its ability to protect bacteria, and could be absorbed from the serum by the particular bacterial strain isolated from the patient. Possible clinical importance of blocking activity by IgG is suggested by the persistent nature of the Ps. aeruginosa infections in these patients.
Similar articles
-
Bactericidal activity of serum from cystic fibrosis patients for Pseudomonas aeruginosa.J Med Microbiol. 1983 Nov;16(4):401-8. doi: 10.1099/00222615-16-4-401. J Med Microbiol. 1983. PMID: 6417338
-
Pseudomonas aeruginosa antibodies in human plasma.Jpn J Exp Med. 1976 Jun;46(3):149-54. Jpn J Exp Med. 1976. PMID: 60502
-
Diagnostic significance of measurements of specific IgG antibodies to Pseudomonas aeruginosa by three different serological methods.J Cyst Fibros. 2009 Jan;8(1):37-42. doi: 10.1016/j.jcf.2008.08.002. Epub 2008 Oct 5. J Cyst Fibros. 2009. PMID: 18835753
-
IgG subclasses and chronic bacterial infection. Subclass antibodies and the clinical course of chronic Pseudomonas aeruginosa lung infection in cystic fibrosis.APMIS Suppl. 1996;66:1-41. APMIS Suppl. 1996. PMID: 8972694 Review. No abstract available.
-
Pseudomonas aeruginosa chromosomal beta-lactamase in patients with cystic fibrosis and chronic lung infection. Mechanism of antibiotic resistance and target of the humoral immune response.APMIS Suppl. 2003;(116):1-47. APMIS Suppl. 2003. PMID: 14692154 Review.
Cited by
-
Anti-LPS IgA and IgG Can Inhibit Serum Killing of Pseudomonas aeruginosa in Patients with Cystic Fibrosis.Infect Immun. 2021 Nov 16;89(12):e0041221. doi: 10.1128/IAI.00412-21. Epub 2021 Aug 30. Infect Immun. 2021. PMID: 34460286 Free PMC article.
-
Mechanism of action of blocking immunoglobulin G for Neisseria gonorrhoeae.J Clin Invest. 1985 Nov;76(5):1765-72. doi: 10.1172/JCI112167. J Clin Invest. 1985. PMID: 3932472 Free PMC article.
-
Serum bactericidal effect on Pseudomonas aeruginosa isolates from cystic fibrosis patients.Infect Immun. 1981 Aug;33(2):512-8. doi: 10.1128/iai.33.2.512-518.1981. Infect Immun. 1981. PMID: 6792079 Free PMC article.
-
Bactericidal and bacteriolytic activity of serum against gram-negative bacteria.Microbiol Rev. 1983 Mar;47(1):46-83. doi: 10.1128/mr.47.1.46-83.1983. Microbiol Rev. 1983. PMID: 6343827 Free PMC article. Review. No abstract available.
-
Characterization of serum resistance of Neisseria gonorrhoeae that disseminate. Roles of blocking antibody and gonococcal outer membrane proteins.J Clin Invest. 1982 Jul;70(1):157-67. doi: 10.1172/jci110589. J Clin Invest. 1982. PMID: 6806319 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources